| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Gene Expression and Insulin Sensitivity in Healthy Young MenDepartments of Human Genetics and Medicine (J.D., K.R.), David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California 90095; and Pennington Biomedical Research Center (L.M.S., H.X., S.R.S.), Baton Rouge, Louisiana 70808
Address all correspondence and requests for reprints to: Karen Reue, University of California, Human Genetics, 6506A Gonda, 695 Charles E. Young Drive South, Los Angeles, California 90095. E-mail: reuek{at}ucla.edu.
 |
Abstract |
|---|
 Top Abstract IntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Objective: Our objective was to determine whether variations in adipose tissue lipin-1 expression levels influence insulin sensitivity and gene expression in young healthy human subjects.
Design and Subjects: In 56 healthy young men (22.6 ± 3.2 yr; 26.4 ± 4.1 kg/m2) we determined insulin sensitivity by a euglycemic-hyperinsulinemic clamp, and whole body oxygen consumption and respiratory quotient by indirect calorimetry. We performed gene expression analysis in adipose tissue samples from human subjects and from lipin-1 transgenic mice using quantitative RT-PCR.
Results: In healthy young men, lipin-1 expression was positively correlated with insulin sensitivity (R2 = 0.22; P < 0.01), insulin-stimulated respiratory quotient (R2 = 0.16; P < 0.01), and maximal oxygen consumption during exercise (R2 = 0.16; P < 0.01). Lipin-1 mRNA levels were also correlated with expression of genes involved in lipid oxidation, uptake, and lipolysis, both in humans and in lipin-1 transgenic mice. The strongest correlation occurred between lipin-1 and peroxisome proliferator-activated receptor 
(R2 = 0.74; P < 1 x 10–7), a nuclear receptor with a key role in fatty acid oxidation.
Conclusion: Lipin-1 expression levels in adipose tissue of healthy young subjects and in mice are correlated with a favorable metabolic profile and expression of fatty acid oxidation genes.
|
Introduction |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
We previously identified lipin-1 (Lpin1), a gene that is highly expressed in adipose tissue and skeletal muscle, as the cause of lipodystrophy and insulin resistance in the fatty liver dystrophy mouse (3). Lipin-1-deficient mice fail to develop sc and visceral white adipose tissue depots, as well as interscapular brown adipose tissue (4, 5). On the other hand, enhanced expression of lipin-1 in adipose tissue or skeletal muscle of transgenic mice leads to obesity (6). Interestingly, despite their greater fat mass, the adipose tissue-specific lipin-1 transgenic mice have improved insulin sensitivity.
Recent studies have revealed that lipin-1 has two cellular functions. First, lipin-1, as well as the related lipin-2 and lipin-3 proteins, act as Mg2+-dependent phosphatidate phosphatase type-1 (PAP1) enzymes, which catalyze a key step in the synthesis of glycerolipids (7, 8, 9). PAP1 converts phosphatidate to diacylglycerol, which serves as the direct precursor of triacylglycerol, and of the phospholipids phosphatidylcholine and phosphatidylethanolamine. Lipin-1 accounts for all of the PAP1 activity in white and brown adipose tissue, providing a mechanism for the lipodystrophy observed in lipin-1-deficient mice (8). Lipin-1 can also act as a transcriptional coactivator. Through direct interaction with peroxisome proliferator-activated receptor (PPAR) and PPAR
coactivator-1 , lipin-1 mediates enhanced expression of PPAR target genes involved in fatty acid oxidation in mouse liver (10). The significance of lipin-1 nuclear receptor coactivator activity in adipose tissue has not been investigated.
The strong effect of lipin-1 expression levels on adiposity and insulin sensitivity in mouse models raises the question of whether variations in lipin-1 expression levels in human adipose tissue likewise influence these traits. Thus far, studies performed on 19 dyslipidemic and 39 normal and obese subjects have shown correlations between lipin-1 expression levels in adipose tissue and indirect measures of insulin sensitivity, such as insulin and glucose levels or glucose tolerance (11, 12). A strong association has also been observed between adipose tissue lipin-1 mRNA expression and basal and insulin-stimulated glucose transport in cultured human adipocytes (13). Although robust correlations were observed in these studies, the ability to make conclusions about the role of lipin-1 as a determinant of insulin sensitivity in these individuals was confounded by the presence of additional risk factors, such as hyperlipidemia and obesity, and by the use of surrogate measures of insulin sensitivity, such as glucose/insulin levels and glucose tolerance. Therefore, we set out to test the hypothesis that variations in lipin-1 expression levels in healthy young individuals are correlated with insulin sensitivity, as determined by euglycemic-hyperinsulinemic clamp. We also investigated the relationship between lipin-1 levels and adiposity, energy metabolism, and lipid metabolism gene expression in adipose tissue. Our results indicate that lipin-1 is correlated with insulin sensitivity and energy balance parameters in healthy young individuals, and may have a role in modulation of gene expression in adipose tissue, including effects on PPAR.
|
Subjects and Methods |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
After providing written informed consent, a cohort of 56 healthy young men, aged 22.6 ± 3.2 yr with a body mass index (BMI) of 26.4 ± 4.1 kg/m2, underwent physical examination, medical laboratory tests, and measurement of body fat by dual-energy x-ray absorptiometry (DXA). Subjects that were not weight stable were excluded from participation. Participants presented to the Pennington inpatient unit and ate a weight-maintaining diet (35% fat, 16% protein, and 49% carbohydrate) prepared by the metabolic kitchen. After 48 h of this diet, a euglycemic-hyperinsulinemic clamp was performed. Earlier studies describe this cohort in terms of skeletal muscle oxidative phosphorylation and metabolic flexibility (14, 15, 16, 17). The present investigation only involves measures made before dietary intervention.
Euglycemic-hyperinsulinemic clamp
Glucose disposal rate (GDR) [mg/kg fat free mass (FFM)·min] during the insulin-stimulated state was measured by a euglycemic-hyperinsulinemic clamp (18). After an overnight fast, insulin (80 mIU/m2 BSA) was administered iv and glucose infused to maintain plasma glucose at 90 mg/dl for 2 h. GDR was expressed in terms of lean body mass, determined by DXA.
Maximal aerobic capacity (VO2max)
Maximal oxygen uptake was determined by a progressive treadmill test to exhaustion (19). Oxygen consumption (VO2) and CO2 production (VCO2) were measured continuously using a breath-by-breath indirect calorimeter (V-Max29 Series; SensorMedics, Yorba Linda, CA).
Body composition and adipose tissue mass
Body fat mass and lean body mass were measured on a Hologic dual-energy x-ray absorptiometer (QDR 4500; Hologic, Inc., Waltham, MA). Visceral adipose tissue mass was measured by multislice CT scanning as previously described (20).
Adipose tissue biopsy
After local anesthesia with lidocaine-bupivacaine, approximately 250 mg tissue was collected using Bergström needle biopsy from the lateral periumbilical sc adipose tissue.
Indirect calorimetry
After an overnight fast, the respiratory quotient (RQ) was measured at baseline by indirect calorimetry, and was measured again over 20 min during the euglycemic-hyperinsulinemic clamp using a DeltaTrac II indirect calorimeter (DATEX-Ohmeda, Helsinki, Finland). Oxidative and nonoxidative glucose disposal was calculated as described by Livesey and Elia (21).
Fat cell size
Fat cell size was determined as previously described (22). Briefly, adipose tissue was fixed in osmium tetrachloride/collidine-HCl, followed by disassociation via urea digestion. Cells were counted on a Multisizer-3 (Beckman Coulter, Fullerton, CA) using a 400-µm aperture (dynamic linear range 12–320 µm) and reported as the mean of all adipocytes more than 22.5 µm.
Laboratory measures
Fasting serum glucose and free fatty acids (FFA) were assayed on a Beckman Synchron CX7 (Beckman Coulter, Brea, CA). Fasting plasma insulin and C peptide were measured on an Immulite autoanalyzer (Diagnostic Products Corp, Los Angeles, CA). Wako (Richmond, VA) reagents were used for FFA determinations, except the FFAs obtained during the period of insulin infusion during the clamp, which were measured in triplicate by HPLC due to a requirement for greater sensitivity (23).
Animal studies
Twelve- to 14-month-old male C57BL/6J aP2-lipin-1b transgenic mice and nontransgenic littermates (6) were fed a diet containing 35% fat and 33% carbohydrate (Bioserve F3282; Bioserve, Frenchtown, NJ) for 6 wk. Epididymal fat pads were dissected and immediately frozen in liquid nitrogen for RNA isolation. Animal studies were performed under the approval of the University of California, Los Angeles institutional animal care and use committee.
RNA and DNA extraction
Total RNA from approximately 200 mg human or mouse adipose tissue was isolated with TRIZOL reagent (Invitrogen, Carlsbad, CA), and human RNA was further purified on RNAEasy columns (QIAGEN, Valencia, CA). The quantity and integrity of the RNA were confirmed with the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA).
Quantitative RT-PCR (qRT-PCR)
All primers and probes for human gene expression analysis were designed using Primer Express version 2.1 (Applied Biosystems, Roche, Branchburg, NJ). Sequences of primers and probes are shown in supplemental Table 1, which is published as supplemental data on The Endocrine Society’s Journals Online web site at http://jcem.endojournals.org. For the human studies, qRT-PCR reactions (24) were performed as one-step reactions in ABI PRISM 7900 (Applied Biosystems) using the following parameters: one cycle of 48 C for 30 min, then 95 C for 10 min, followed by 40 cycles at 95 C for 15 sec, and 60 C for 1 min. 18S rRNA was quantitated as a normalization control. For mouse gene expression analysis, qRT-PCR was performed with the iCycler (Bio-Rad Laboratories, Hercules, CA) using SYBR Green PCR reagents (QIAGEN). Gene expression was normalized to the housekeeping genes hypoxanthine phosphoribosyltransferase and β-2 microglobulin.
Statistical analysis
Population characteristics are represented as means ± SD. Gene expression and clinical data were correlated using regression analysis. ANOVA was used to test for differences in biopsy and blood parameters, with post hoc testing by mean equality contrast between different groups using the Tukey-Kramer HSD ( = 0.05). Type I error rate was set a priori at P < 0.05. Analysis was performed using JMP version 5.0 (SAS Institute Inc., Cary, NC).
|
Results |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
We studied 56 young healthy men (22.6 ± 3.2 yr; 26.4 ± 4.1 kg/m2) for a possible relationship between adipose tissue lipin-1 expression levels and parameters associated with adiposity and glucose homeostasis. The characteristics of our study population are shown in Table 1
. Measurements reported here were performed while subjects were inpatients on a weight-maintaining diet. In studies described here, we quantitated expression levels of total lipin-1, as well as the individual lipin-1a and lipin-1b isoforms, which are produced from the LPIN1 gene through alternative mRNA splicing (25). Lipin-1a, lipin-1b, and total lipin-1 mRNA levels were highly intercorrelated, (R2 = 0.83–0.87), so for clarity of presentation, we refer to the total lipin-1 mRNA levels in the text, and include the experimental data for lipin-1a and lipin-1b isoforms in supplemental Tables 2–4, which are published as supplemental data on The Endocrine Society’s Journals Online web site at http://jcem.endojournals.org.
|
and Table 2). This correlation remained statistically significant even when analyzed without an apparent outlier (with a GDR of approximately 24 and a lipin mRNA of about 2.25), and when adjusted for adiposity (P = 0.03). A negative correlation was observed between lipin-1 expression levels and percent body fat, fat cell size, and fasting FFAs (Fig. 1, B–D). Lipin-1 was also negatively correlated with total adipose tissue mass (R2 = 0.20; P < 0.01), deep sc adipose tissue mass (R2 = 0.24; P < 0.01), sc adipose tissue mass (R2 = 0.20; P < 0.01), and visceral adipose tissue mass (R2 = 0.11; P < 0.05).
|
|
Previous indirect calorimetry studies of lipin-1 deficient mice implicated lipin-1 in metabolic switching between glucose and fatty acid substrates during fed and fasted states, as determined by measurements of RQ (26). To investigate whether a relationship exists between lipin-1 expression and substrate switching in humans, we measured RQ in fasted and insulin-stimulated states, before and during the euglycemic-hyperinsulinemic clamp. No significant correlation was observed between lipin-1 and fasting RQ (Fig. 2A). However, insulin-stimulated RQ at steady state during the clamp showed a positive correlation with lipin-1 expression (R2 = 0.16; P < 0.01) (Fig. 2B), consistent with increased insulin-stimulated glucose disposal. There was also a positive correlation between lipin-1 expression and maximum oxygen consumption during exercise (VO2max; R2 = 0.16; P < 0.01) (Table 2
).
|
The results described previously indicate that there is a positive relationship between lipin-1 expression levels and a favorable metabolic profile, including improved insulin sensitivity, and reduced adipose tissue mass, adipocyte cell size, and FFA levels. Because lipin-1 functions as a transcriptional coactivator of PPAR in liver (10), we hypothesized that lipin-1 levels may exert similar effects on expression of PPAR and its target genes in adipose tissue, which could contribute to the changes in metabolic parameters described previously. To test this possibility, we investigated the potential relationship between lipin-1 expression levels and PPAR, as well as other genes with key roles in lipid metabolism, in adipose tissue from humans and from transgenic mice with enhanced lipin-1 expression.
In human adipose tissue, we observed a striking positive correlation between lipin-1 and PPAR mRNA levels (R2 = 0.74; P < 1 x 10–7) (Fig. 3A). The PPAR target gene medium-chain acyl-coenzyme A dehydrogenase (MCAD) also had a strong positive correlation with lipin-1 (R2 = 0.68; P < 1 x 10–7) (Fig. 3B). Lipin-1 also showed positive correlations with phosphoenol pyruvate carboxykinase (PCK1), fatty acid synthase (FAS), CD36, Cbl-associated protein (CAP), stearoyl coenzyme A desaturase-1 (SCD1), hormone-sensitive lipase (HSL), adipose tissue triglyceride lipase (ATGL), and perilipin (Table 3). As such, lipin-1 expression levels are correlated with genes involved in both fatty acid utilization/oxidation (PPAR, MCAD, CD36, ATGL, and HSL), and genes involved in lipid biosynthesis (SCD1 and FAS). Lipoprotein lipase (LPL) did not exhibit a significant correlation with lipin-1 expression, nor did several other genes investigated in these samples, such as adipose tissue inflammatory markers (CD68, MAC-2, monocyte chemoattractant protein-1, macrophage inhibitory protein-1 alpha; data not shown).
|
|
and other lipid metabolism genes that were positively correlated with lipin-1 expression in human adipose tissue. If true, we would predict that constitutively high lipin-1 expression levels in adipose tissue would lead to increased expression of PPAR and other genes. To address this possibility, we investigated whether the aP2-lipin-1 transgenic mouse, which exhibits a 4-fold constitutive increase in lipin-1 expression in adipose tissue (6) (Fig. 4A), also has elevated expression of genes showing a positive correlation with lipin-1 levels in human adipose tissue. Compared with nontransgenic littermates, the aP2-lipin-1 transgenic mice showed a significant increase in the expression of CD36, FAS, PPAR, MCAD, and HSL (P < 0.05) (Fig. 4A). As with human adipose tissue, we did not observe evidence for a relationship between lipin-1 and LPL, which had similar levels in wild-type and transgenic mice (data not shown). To exclude the possibility that the altered gene expression in the aP2-lipin-1 transgenic mice is related to the increased adiposity compared with nontransgenic animals (6), we also examined gene expression levels in another model of increased adiposity, the leptin-deficient ob/ob mouse. Unlike the lipin-1 transgenic animals, ob/ob mice had reduced mRNA levels compared with wild-type littermates for lipin-1, PPAR, MCAD, FAS, and HSL (Fig. 4B), indicating that the elevation of these genes does not occur simply as a consequence of increased adipose tissue mass. CD36 was increased in both aP2-lipin-1 transgenic and ob/ob mice, and may, therefore, be related to increased adiposity.
|
|
Discussion |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
, which recently was shown to be regulated by lipin-1 in mouse liver (10). Lipin-1 was positively correlated with GDR during a euglycemic-hyperinsulinemic clamp, providing the most direct evidence so far that lipin-1 mRNA levels in adipose tissue are positively correlated with insulin sensitivity. Furthermore, these results demonstrate that this relationship holds true even in healthy young subjects. Together with previous studies, these results establish that enhanced lipin-1 expression levels in adipose tissue are associated with insulin sensitivity over a broad spectrum of BMI, ranging from lean to obese, and healthy to glucose-intolerant individuals (11, 12). There are several possible mechanisms for the observed relationship between lipin-1 expression and insulin sensitivity. Previous studies revealed that lipin-1 expression levels in adipose tissue are correlated with both basal and insulin-stimulated glucose uptake in human adipocytes (13), and inversely correlated with lipid accumulation in skeletal muscle (12). Here, we detected a positive correlation between lipin-1 mRNA and insulin-stimulated RQ, suggesting that lipin-1 is associated with the ability to switch substrate oxidation from fat to carbohydrate upon insulin stimulation.
Consistent with its positive correlation with insulin sensitivity, lipin-1 also showed a negative correlation with measures of adiposity, including total, visceral, and sc adipose tissue mass, as well as fat cell size and BMI. Previous studies have also noted an inverse correlation between lipin-1 and BMI (11, 12, 27). Given the known role of lipin-1 in triglyceride biosynthesis in adipose tissue, these results may at first appear counterintuitive. However, they are in line with the demonstration that adipose tissue lipogenic capacity and lipogenic enzyme gene expression are decreased in human obesity (28, 29). In addition, emerging information about the function of lipin-1 indicates that its molecular role extends beyond its PAP1 enzyme function to include gene regulatory activity (10). Indeed, the current study provides in vivo evidence for a correlation between lipin-1 mRNA levels and the expression in human adipose tissue of PPAR and other genes that have been implicated as regulatory targets (discussed below). Thus, the mechanisms by which lipin-1 mRNA levels influence adiposity and insulin sensitivity may be clarified as the biochemical and molecular processes that regulate the dual actions of lipin-1 are elucidated.
We also detected a strong positive correlation between expression levels of lipin-1 and genes with key roles in fatty acid oxidation—PPAR and MCAD. This relationship held true in transgenic mouse adipose tissue, in which enhanced lipin-1 expression driven by a heterologous promoter led to enhanced PPAR and MCAD expression. In the aP2-lipin-1 transgenic mice, the only difference from wild-type mice at the genomic level is the lipin-1 transgene, which confers a 3- to 4-fold increase in lipin-1 mRNA levels in adipose tissue. Thus, changes in gene expression in the adipose tissue of this model are either directly or indirectly related to the increased lipin-1 expression. Although these correlations between lipin-1 and PPAR expression do not establish mechanism, it is relevant that in mouse liver, lipin-1 expression induces the expression of PPAR and also acts as a coactivator for PPAR, resulting in the activation of fatty acid oxidation genes (10). Thus, our results raise the possibility that lipin-1 may play an analogous role in adipose tissue, acting as a regulator of PPAR expression and/or coactivator activity. In that case, enhanced lipin-1 expression could lead to increased fatty acid oxidation in adipose tissue, and improved metabolic homeostasis. In addition, there were strong positive correlations between lipin-1 and lipid storage genes (PCK1, SCD1 and FAS) and lipolysis genes (perilipin, ATGL, HSL, and CAP). It remains to be determined whether lipin-1 can directly modulate expression of these genes via its transcriptional coactivator function.
The one discrepancy that we have noted between human and mouse is that in human adipose tissue, lipin-1 levels were inversely correlated with adiposity, whereas in the aP2-lipin-1 transgenic mouse, we previously showed a positive correlation (6). We do not know the basis for this difference, but it may be related to the fact that the increased lipin-1 gene expression in aP2-lipin-1 transgenic mice is constitutively up-regulated via heterologous regulatory elements and, therefore, not responsive to molecular or physiological signals that normally modulate lipin-1 levels. Because lipin-1 is a required PAP1 enzyme for triacylglycerol synthesis in adipose tissue, forced expression may be responsible for the enhanced triglyceride accumulation in adipose tissue of lipin-1 transgenic mice, whereas in normal human subjects, lipin-1 gene expression in fat cells may be attenuated upon reaching a normal, mature fat cell size. Support for this possibility comes from studies demonstrating that in cases in which human adipose tissue is not at its normal triglyceride storage capacity, as in lipodystrophy, lipin-1 expression levels are positively correlated with fat mass (30).
In summary, we provide evidence that lipin-1 expression levels in adipose tissue are correlated with adiposity, insulin sensitivity, and oxidative, lipogenic, and lipolytic gene expression in adipose tissue from healthy young human subjects. Correlations between lipin-1 gene expression levels and that of several other lipid metabolism genes were also observed in adipose tissue from aP2-lipin-1 transgenic mice, suggesting that expression of these genes may be driven either directly or indirectly by lipin-1. Notably, the expression levels of PPAR, a target of lipin-1 transcriptional coactivator activity, were strongly positively correlated with lipin-1 levels in human and transgenic mouse adipose tissue. Induction of PPAR and its target genes involved in fatty acid oxidation may be a mechanism by which lipin-1 levels influence insulin sensitivity.
|
Footnotes |
|---|
Abbreviations: ATGL, Adipose tissue triglyceride lipase; BMI, body mass index; CAP, Cbl-associated protein; DXA, dual-energy x-ray absorptiometry; FAS, fatty acid synthase; FFA, free fatty acid; FFM, fat free mass; GDR, glucose disposal rate; HSL, hormone-sensitive lipase; Lpin1, lipin-1; LPL, lipoprotein lipase; MCAD, medium-chain acyl-coenzyme A dehydrogenase; PAP1, phosphatidate phosphatase type-1; PCK1, phosphoenol pyruvate carboxykinase; PPAR, peroxisome proliferator-activated receptor; qRT-PCR, quantitative RT-PCR, respiratory quotient; SCD1, stearoyl coenzyme A desaturase-1; VO2max, maximal aerobic capacity.
This work was supported by National Institutes of Health Grants HL-28481 (to K.R.), DK-72476 (to S.R.S.), and Genomic Analysis Training Grant S-T32-HG002536 (to J.D.), and the United States Department of Agriculture Grant 58-6435-5-017 (to S.R.S.).
Disclosure Statement: The authors have nothing to disclose.
Received July 10, 2007.
Accepted October 1, 2007.
|
References |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
is critical for adipogenesis in vivo and in vitro. J Biol Chem 279:29558–29564/PPAR regulatory pathway. Cell Metab 4:199–210[CrossRef][Medline] activation. Diabetes 55:2811–2818This article has been cited by other articles:
 |
|
 |
|
  J. Donkor, P. Zhang, S. Wong, L. O'Loughlin, J. Dewald, B. P.C. Kok, D. N. Brindley, and K. Reue A Conserved Serine Residue Is Required for the Phosphatidate Phosphatase Activity but Not the Transcriptional Coactivator Functions of Lipin-1 and Lipin-2 J. Biol. Chem., October 23, 2009; 284(43): 29968 - 29978. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Douglas, J. L. Moran, J. R. Bermingham Jr, X.-J. Chen, D. N. Brindley, B. Soliven, D. R. Beier, and B. Popko Concurrent Lpin1 and Nrcam Mouse Mutations Result in Severe Peripheral Neuropathy with Transitory Hindlimb Paralysis J. Neurosci., September 30, 2009; 29(39): 12089 - 12100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Takeuchi and K. Reue Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis Am J Physiol Endocrinol Metab, June 1, 2009; 296(6): E1195 - E1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Reue and J. R. Dwyer Lipin proteins and metabolic homeostasis J. Lipid Res., April 1, 2009; 50(Supplement): S109 - S114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Mlinar, M. Pfeifer, E. Vrtacnik-Bokal, M. Jensterle, and J. Marc Decreased lipin 1{beta} expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome Eur. J. Endocrinol., December 1, 2008; 159(6): 833 - 839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Reue and D. N. Brindley Thematic Review Series: Glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism J. Lipid Res., December 1, 2008; 49(12): 2493 - 2503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Lu, Y. Lu, A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold LPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1502 - E1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zhang, L. O'Loughlin, D. N. Brindley, and K. Reue Regulation of lipin-1 gene expression by glucocorticoids during adipogenesis J. Lipid Res., July 1, 2008; 49(7): 1519 - 1528. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
